MEREO BIOPHARMA GROUP PLC (MREO) Total liabilities 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) total liabilities at each fiscal year-end, per SEC filings.
$5.0MFY2025 · since FY2022: $26.0M → $5.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.0M | -67.6% |
| FY2024 | $15.4M | -3.4% |
| FY2023 | $16.0M | -38.6% |
| FY2022 | $26.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MREO financial trends
MREO RevenueMREO Net incomeMREO Net marginMREO Gross profitMREO Gross marginMREO Operating incomeMREO Operating marginMREO Operating cash flowMREO Free cash flowMREO Capital expendituresMREO Return on equityMREO Stock buybacksMREO Dividends paidMREO Total assetsMREO Shareholders’ equityMREO overview →